GlassScriptPhysician profile
Marvin N Bleiberg
NPI 1356307052
$7,670.97
in general payments reported to CMS, 2019-2025
43 companies · $662 in 2025
The $662 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,917 · 2020: $659 · 2021: $1,629 · 2022: $1,296 · 2023: $847 · 2024: $662 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,170.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,112.13 | 2019-2024 | Proclaim |
| Pfizer INC. | $822.77 | 2019-2025 | |
| Abbvie INC. | $790.86 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Boston Scientific Corporation | $575.54 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $560.39 | 2019-2024 | Ztlido |
| Merz Pharmaceuticals, LLC | $416.04 | 2021-2025 | Xeomin |
| Biohaven Pharmaceuticals, INC. | $353.58 | 2021 | |
| Lilly USA, LLC | $352.60 | 2019-2024 | Emgality, Reyvow |
| Takeda Pharmaceuticals U.S.A., INC. | $257.90 | 2019-2023 | Trintellix |
| Collegium Pharmaceutical, INC. | $235.56 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $220.58 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $187.45 | 2019-2022 | |
| Amgen INC. | $186.42 | 2020-2022 | |
| Sentynl Therapeutics, INC. | $178.55 | 2019 | |
| Assertio Therapeutics, INC. | $177.26 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Bleiberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.